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Measurement of alphafetoprotein (AFP) in amniotic fluid is the important step in the diagnosis of neural tube defects (NTD) of the fetus. Current methods include immunodiffusion, counter-immunoelectrophoresis, enzyme immunoassay, and radioimmuncassay (Chard, 1978) . Though fluoroimmunoassay (FIA) has been applied to a number of antigens (Shaw et al., 1977; Chard and Sykes, 1979) , it has not so far been used for AFP. We describe here the development of a separation FIA for amniotic fluid AFP.
Solutions of AFP (2'0 mg/rnl) (MW 70000) ( A1-Awqati et al., 1978) and fluorescein isothiocyanate (FlTC) (1 rngjrnl) (MW 389-4) (Calbiochem) were prepared in 0'15M Na2HP04 2H20, pH 9·5. The protein solution (500~1) was mixed with 33'6, 56'0, or 84'0~l of FITC solution (12, 20, and 30 molecules FITC/molecule AFP respectively), incubated for 2 hours at room temperature, applied to a 5 x 75 mrn column of Bie-gel P4 (Bic-Rad Laboratories), and eluted with phosphate buffer (pH 9'5). Fractions of 250~l were collected, and fluorescence was determined in a Perkin-Elmer 2000 spectrofluorometer with a 492 nm excitation filter and measurement of emission at 546 nm. The protocol of the FIA was similar to that of the RIA (Leek et al., 1975) . After separation of bound and free AFP the supernatant was diluted with one volume of distilled water and fluorescence was determined.
Amniotic fluid samples were obtained from 69 women at 16-20 weeks' gestation and stored at -20°C for up to one year until assay. Forty pregnancies had a normal outcome, while 28 women had terminations as a result of abnormal AFP levels measured by RIA. Normal amniotic fluid samples were assayed without dilution, and abnormal samples were diluted 1:10 with phosphate buffer. With a tracer concentration of approximately 500 ng FITC/AFP per tube the standard curve was very similar to that obtained by RIA ( Figure 1 ) using similar conditions. There was no obvious difference between tracers at different levels of FITC substitution. For the individual amniotic fluid samples examined by FIA and RIA the correlation (r value) was 0'98, and the slope of the regression line was 0·95. The between-assay coefficient of variation for two quality control pools with mean values of 14·4 tngll and 22'8 rng/I were 12·5 % and 10·3 % respectively.
These findings demonstrate the feasibility of a fluoroimmunoassay for AFP. The potential advantages of this procedure are: (1) together with other immunoassays employing labelled antigen the results are largely independent of the specificity of the antiserum; (2) the label is non-isotopic and should therefore have a prolonged shelf-life; (3) there is no radiation hazard; and (4) the end-ponit is simpler to determine than that of an enzyme immunoassay since fluorescence is time and temperature independent. The disadvantages are: (l) a relatively high tracer concentration is required which places heavy demands on the supply of purified antigen; and (2) end-point detection is less sensitive than that of a radio-isotope, and it has not, as yet, been possible to devise an assay with precision adequate for the estimation of AFP in maternal serum. Current work is directed towards improvement of the equipment in order that the latter aim can be achieved.
Identity of an oligosaccharide present in faeces in breast-fed neonates DEBORAH C. SAUNDERS and CHARLES A. PENNOCK Department of Child Health, University of Bristol, Bristol Maternity Hospital, Southwell Street, Bristol BS28EG It has recently been suggested that methods for the examination of sugars in faeces may be inadequate for the separation of lactose from other more complex carbohydrates. One recent study has shown that the commonest carbohydrate present in the first week of life is an oligosaccharide which is difficult to separate from lactose using conventional sugar chromatographic methods. Acid hydrolysis releases glucose and galactose so that the oligosaccharide may be identified falsely as lactose (Whyte et al., 1978) .
A sample of faeces obtained from a normal, healthy, breast-fed infant was examined by the methods described by Whyte et al. (1978) , and the presence of the oligosaccharide was confirmed. The faecal extract was compared with samples of expressed human breast milk using a new thin-layer chromatographic (TLC) procedure for the study of oligosaccharides (West, 1978) using n-butanol: glacial acetic acid: 1 M-lactic acid (2:1 :1) as developing solvent and orcinol reagent for location. Preparative TLC was performed on silica gel G plates, 2mm thick, and the bands were located by spraying the edges of the plate. The oligosaccharide separated from lactose in this solvent and the band of silica gel containing it was removed and the oligosaccharide was eluted with water. The eluate was centrifuged and the supernatant was dried down in a vacuum desiccator over phosphorus pentoxide. A portion was hydrolysed in an equal volume of O'IM sulphuric acid in sealed ampoules at 90°C for 1 hour, and the products were examined by TLC in the solvent system described by Whyte et al. (1978) . The oligosaccharide was subjected to methanolysis and the products were silylated and examined by gas-liquid chromatography (GLC) using the method of Clamp (1977) with a Micromass 16 mass spectrometer attached to the gas chromatograph.
The oligosaccharide was inadequately separated from lactose, but in the alternative solvent system it was easy to distinguish (Rr relative to lactose = 0'82) and migrated in the same position as the major oligosaccharide present in human breast
